O
CNC icon

OrbiMed’s Centene CNC Stock Holding History

OrbiMed’s Portfolio CNC Stock Details CNC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,993,700
Closed -$120M – 164
2020
Q4 		$120M Buy
1,993,700
+658,000
+49% +$41.8M 1.05% 25
2020
Q3 		$77.9M Hold
1,335,700
– – 0.98% 30
2020
Q2 		$84.9M Hold
1,335,700
– – 1.2% 27
2020
Q1 		$79.4M Buy
+1,335,700
New +$81M 1.33% 28
2019
Q1 		– Sell
-834,800
Closed -$48.1M – 130
2018
Q4 		$48.1M Buy
834,800
+160,000
+24% +$10.7M 0.89% 39
2018
Q3 		$48.8M Buy
+674,800
New +$46.9M 0.59% 53
2017
Q2 		– Sell
-3,311,400
Closed -$118M – 143
2017
Q1 		$118M Buy
+3,311,400
New +$111M 1.34% 23
2013
Q4 		– Sell
-1,673,200
Closed -$26.8M – 126
2013
Q3 		$26.8M Hold
1,673,200
– – 0.48% 47
2013
Q2 		$21.9M Buy
+1,673,200
New +$20.3M 0.47% 45

Other funds holding CNC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

OrbiMed's CNC Position: Q1 2021 in Review

OrbiMed sold out of Centene (CNC) in Q1 2021, closing a stake of 1,993,700 shares — an estimated $120M sold.

OrbiMed first reported a position in CNC in Q2 2013 and held it in 9 quarters. The position peaked at $120M in Q4 2020. 780 funds tracked by Wall St. Rank hold CNC as of Q1 2021.

  • OrbiMed reported no remaining Centene position as of Q1 2021 after selling out during the quarter.
  • OrbiMed sold 1,993,700 Centene shares in Q1 2021, an estimated $120M.
  • OrbiMed first reported a position in Centene in Q2 2013 and held it in 9 quarters.
  • OrbiMed's Centene position peaked at $120M in Q4 2020.
  • 780 funds tracked by Wall St. Rank held Centene as of Q1 2021.

Based on OrbiMed's 13F filing for Q1 2021, filed 17 May 2021.